Development of an automated assessment tool for MedWatch reports in the FDA adverse event reporting system

Conclusion:</strong> Our models produced prioritized report orderings that enable FDA safety evaluators to focus on reports that are more likely to contain valuable medication-related adverse event information. Applying our models to all FDA adverse event reports has the potential to streamline the manual review process and greatly reduce reviewer workload.</span>
Source: Journal of the American Medical Informatics Association - Category: Information Technology Source Type: research